Ziel
The current Ebola Virus Disease (EVD) outbreak has caused more than 5000 deaths within a few months in West Africa (Guinea, Sierra Leone and Liberia being the most severely affected countries), including numerous healthcare workers. It is now is serious public health crisis of international concern . The numbers of cases are still increasing 11 months after the first case was described (December 2013), by mid November 2014 approximately 15000 individuals have been infected and the epidemic is still not under control The direct effects of this outbreak include disruption of standard medical care, insecurity and social disruption in countries that were already struggling to recover from decades of war. One of the most important key actions to limit and stop the spread of this deadly disease is to identify and isolate the EBOV-infected patients. The diagnosis of Ebola Virus infections has in the past, been performed overwhelmingly in specialist reference laboratories with high-performance molecular, serological and culture methods.In recent years many of these functions have been mobilised into rapid response mobile laboratories, indeed several of these units supported by, European, CDC/USA, Canadian, Chinese and African states have been set up to help in the current outbreak by performing laboratory diagnosis, in collaboration with national centres in West Africa. While this type of response has been effective in helping control past EVD outbreaks in rural parts of Africa, it has not been as effective at controlling the current outbreak which is now spreading in densely populated city and slum areas. Unfortunately, the diagnostic procedures currently used in the mobile laboratories are associated with several problems: i) there are a limited number of diagnostic hubs, ii) performing the diagnostic tests correctly requires specialist training, skill and experience, consequently there a limited numbers of trained staff
Wissenschaftliches Gebiet
- medical and health scienceshealth sciencespublic health
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesebola
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health sciencesbasic medicineimmunology
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
H2020-JTI-IMI2-2014-02-single-stage
Andere Projekte für diesen Aufruf anzeigenFinanzierungsplan
IMI2-RIA - Research and Innovation actionKoordinator
171 82 Solna
Schweden
Auf der Karte ansehen
Beteiligte (17)
75654 Paris
Auf der Karte ansehen
DAKAR Dakar
Auf der Karte ansehen
10691 Stockholm
Auf der Karte ansehen
5032 GEMBLOUX
Auf der Karte ansehen
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).
1165 Kobenhavn
Auf der Karte ansehen
LS2 7UE Leeds
Auf der Karte ansehen
00149 Roma
Auf der Karte ansehen
75724 Paris
Auf der Karte ansehen
2300 Kobenhavn S
Auf der Karte ansehen
13284 Marseille
Auf der Karte ansehen
FK9 4LA Stirling
Auf der Karte ansehen
20121 MILANO
Auf der Karte ansehen
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).
00014 Helsingin Yliopisto
Auf der Karte ansehen
20122 Milano
Auf der Karte ansehen
13125 Berlin
Auf der Karte ansehen
75015 PARIS
Auf der Karte ansehen
20014 Turku
Auf der Karte ansehen